266 Outcome Evaluation of Volume-Staged Stereotactic Radiosurgery for Cerebral Arteriovenous Malformations

View at publisher Summarise with VIRAT
Authors: Georgios Mantziaris, Bardia Hajikarimloo, Salem M Tos, Stylianos Pikis, Jason Chan, Penny K. Sneed, Michael W. McDermott, Zachary Seymour, Inga Siiner Grills, Ahmed Nabeel, Wael Abdel Halim Reda, Sameh R. Tawadros
+50 more Khaled Abdelkarim, Amr M. N. El-Shehaby, Reem M. Emad, Othman Bin-Alamer, L. Dade Lunsford, Ajay Niranjan, Selçuk Peker, Yavuz Samancı, Cheng-Chia Lee, Huai‐Che Yang, Darrah E. Sheehan, Kimball A. Sheehan, Roman Liščák, Tomáš Chytka, Juan D. Alzate, Douglas S Kondziolka, Ying Meng, Nuria Martínez Moreno, Roberto Martínez Álvarez, David R Hallan, Chanju Fritch, Francis J. Jareczek, Bao Yue Sciscent, David Mathieu, Louis Carrier, Ahmed Abdelsalam, Robert M. Starke, Carolina Benjamin, Timóteo Almeida, S.P. Singh, Manjul Tripathi, Herwin Speckter, Erwin Lazo, Ching‐Jen Chen, Yoshua Esquenazi, Andrea Becerril‐Gaitan, Mark J. Amsbaugh, Angel I. Blanco, Rituraj Upadhyay, Joshua David Palmer, Andrea Franzini, Piero Picozzi, Andrea Luigi Lanterna, Greg N. Bowden, Jennifer L. Peterson, Ronald E. Warnick, Veronica Chiang, Mariam Ishaque, Maria Protopapa, Jason P. Sheehan
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Single-session stereotactic radiosurgery (SRS) has limited role for large arteriovenous malformations (AVM). Volume-staged SRS (VS-SRS) is used to optimize outcomes but studies reporting results are limited. METHODS: This multicenter retrospective cohort of 378 patients from 21 centers reports results of VS-SRS for the entire AVM nidus. We report favorable outcome, obliteration, hemorrhage, and permanent symptomatic adverse radiation effect (ARE) rates. RESULTS: The median age was 31 years (Interquartile [IQR]: 19-44) at the first volume stage, with patients treated in 2–4 stages. The median total nidus volume was 21 cm3 (IQR: 13.9-30.1 cm3) and a median prescription dose of 17 Gy (IQR: 16-18Gy) was used. The median radiographic and clinical follow-up were 48 and 55 months, respectively. Seventy-seven (20.4%) patients had a favorable outcome, with the 3- and 5-year rates being 3.9% and 18%. 127 (33.6%) patients achieved obliteration, with the 3- and 5-year rates being 6.8% and 26%. Obliteration rates of AVMs

Fields of Study & Subjects

Vascular Malformations Diagnosis and Treatment Vascular Malformations and Hemangiomas Vascular Anomalies and Treatments

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
64–65
Publication date
26 March 2026
Language
EN